Skip to main content

Table 1 Patient demographics and comparisons

From: The use of dielectric blood coagulometry in the evaluation of coagulability in patients with peripheral arterial disease

   1 MHz, Tmax 10 MHz, Tmax
Variables Number Median P-value Median P-value
Gender (Male: Female) 41: 8 1320: 1260 0.569 1620: 1500 0.705
Smoking history (+: -) 42: 7 1320: 1320 0.841 1560: 1800 0.852
Hypertension (+: -) 32: 17 1290: 1440 0.338 1500: 1740 0.152
Dyslipidemia (+: -) 25: 24 1260: 1440 0.173 1500: 1650 0.652
Coronary artery disease (+: -) 5: 44 1320: 1320 0.987 1740: 1560 0.741
Cerebrovascular disease (+: -) 9: 40 1200: 1410 0.1473 1500: 1650 0.224
Chronic kidney disease (+: -) 11: 38 1080: 1380 0.167 1260: 1710 0.052
Diabetes mellitus (+: -) 22: 27 1170: 1500 0.010 1470: 1800 0.011
Ca-blocker (+: -) 24: 25 1320: 1320 0.711 1500: 1680 0.331
β-blocker (+: -) 6: 43 1500: 1320 0.492 1680: 1560 0.783
ACE-I (+: -) 2: 47 1440: 1320 0.667 1620: 1560 0.859
ARB (+: -) 20: 29 1290: 1320 0.714 1500: 1680 0.154
Statin (+: -) 22: 27 1260: 1440 0.487 1620: 1560 0.840
Antiplatelet (+: -) 44: 5 1350: 1320 0.620 1560: 1620 0.408
  1. IQR interquartile range; ACE-I angiotensin converting enzyme – inhibitor; ARB angiotensin II receptor blocker
\